Diphenhydramine Hydrochloride USP For Compounding (API)
Diphenhydramine Hydrochloride USP for Compounding (API) is an active pharmaceutical ingredient used in the preparation of customized medications, typically within a compounding pharmacy setting. It is an antihistamine that is primarily used to alleviate symptoms associated with allergies, such as itching, rashes, and runny nose. Additionally, it is effective in managing symptoms of the common cold, reducing motion sickness, and providing relief from sleeplessness due to its sedative properties. Diphenhydramine's versatility makes it suitable for compounding into various dosage forms like capsules, liquids, and topical applications, tailored to individual patient needs.
Diphenhydramine Hydrochloride, USP is a compound used in the medical and pharmaceutical industry. It is an antihistamine and sedative drug that works by blocking the effects of histamine in the body, reducing the symptoms of allergies, such as nasal congestion, itching, and hives.
The "USP" in the name stands for United States Pharmacopeia, which is the official public standard-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured in the United States.
In compounding, Diphenhydramine Hydrochloride, USP may be used as an ingredient in medications mixed together specifically for individual patients, as per their specific needs. This allows for personalized and tailored treatments, especially for those with allergies and other related conditions.